SARAH WIERDA: Open Payments
NPI 1316439052 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 18 payments from 10 companies in 2025. Trend: 2023 $141 · 2024 $78 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $88 |
| Antares Pharma, Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Hologic Sales and Service, LLC | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: XYOSTED, SHINGRIX, CAPLYTA, Ozempic, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, QULIPTA, THINPREP 2000 PROCESSOR, VRAYLAR.
Industry payments across CO — which companies pay providers there.
